Business Description
Inari Medical Inc
NAICS : 334510
SIC : 3845
ISIN : US45332Y1091
Share Class Description:
NARI: Ordinary SharesDescription
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.41 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.94 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 8.31 | |||||
| Beneish M-Score | 8.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 47.5 | |||||
| 3-Year EBITDA Growth Rate | -5.5 | |||||
| 3-Year Book Growth Rate | 25.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 19.04 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 89.05 | |||||
| 9-Day RSI | 80.53 | |||||
| 14-Day RSI | 73.93 | |||||
| 3-1 Month Momentum % | 18.37 | |||||
| 6-1 Month Momentum % | 12.15 | |||||
| 12-1 Month Momentum % | -14.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | |||||
| Quick Ratio | 1.4 | |||||
| Cash Ratio | 0.75 | |||||
| Days Inventory | 223.95 | |||||
| Days Sales Outstanding | 48.41 | |||||
| Days Payable | 62.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.5 | |||||
| Shareholder Yield % | -0.11 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 86.82 | |||||
| Operating Margin % | -7.38 | |||||
| Net Margin % | -13.68 | |||||
| FCF Margin % | 0.28 | |||||
| ROE % | -17.68 | |||||
| ROA % | -12.07 | |||||
| ROIC % | -15.95 | |||||
| 3-Year ROIIC % | -2.9 | |||||
| ROC (Joel Greenblatt) % | -52.71 | |||||
| ROCE % | -9.68 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 415.79 | |||||
| PS Ratio | 5.88 | |||||
| PB Ratio | 7.82 | |||||
| Price-to-Tangible-Book | 43.83 | |||||
| Price-to-Free-Cash-Flow | 2078.93 | |||||
| Price-to-Operating-Cash-Flow | 238.57 | |||||
| EV-to-EBIT | -62.75 | |||||
| EV-to-EBITDA | -95.48 | |||||
| EV-to-Revenue | 5.79 | |||||
| EV-to-Forward-Revenue | 4.66 | |||||
| EV-to-FCF | 2105.66 | |||||
| Price-to-GF-Value | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 2817.5 | |||||
| Earnings Yield (Greenblatt) % | -1.69 | |||||
| FCF Yield % | 0.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NARI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inari Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 574.498 | ||
| EPS (TTM) ($) | -1.35 | ||
| Beta | 0.59 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 54.25 | ||
| 14-Day RSI | 73.93 | ||
| 14-Day ATR ($) | 2.304587 | ||
| 20-Day SMA ($) | 51.4975 | ||
| 12-1 Month Momentum % | -14.16 | ||
| 52-Week Range ($) | 36.73 - 67.13 | ||
| Shares Outstanding (Mil) | 58.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inari Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inari Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inari Medical Inc Frequently Asked Questions
What is Inari Medical Inc(NARI)'s stock price today?
The current price of NARI is $56.35. The 52 week high of NARI is $67.13 and 52 week low is $36.73.
When is next earnings date of Inari Medical Inc(NARI)?
The next earnings date of Inari Medical Inc(NARI) is 2025-02-28 Est..
Does Inari Medical Inc(NARI) pay dividends? If so, how much?
Inari Medical Inc(NARI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers